Corpus Intelligence IC Memo — PEAK VIEW BEHAVIORAL HEALTH 2026-04-26 12:36 UTC
IC Memo — PEAK VIEW BEHAVIORAL HEALTH
Investment Committee Memorandum | CO | 112 beds | Grade C | EBITDA uplift $2.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PEAK VIEW BEHAVIORAL HEALTH

CCN 064026 | EL PASO, CO | 112 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PEAK VIEW BEHAVIORAL HEALTH is a 112-bed safety-net/medicaid heavy in EL PASO, CO with $35.9M in net patient revenue and a 18.9% operating margin. The hospital serves a payer mix of 4.5% Medicare, 33.9% Medicaid, and 61.6% commercial.

Thesis: Turnaround. Our ML models identify $2.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 18.9% to 26.3% (+736bps).

Net Revenue HCRIS$35.9M
Current EBITDA COMPUTED$6.8M
Operating Margin COMPUTED18.9%
Occupancy HCRIS83.4%
Revenue / Bed COMPUTED$321K
Net-to-Gross HCRIS38.0%
Distress Probability ML49.1%

2. Market Context & Competitive Position

108
CO Hospitals
-3.6%
State Median Margin
34
Comparable Hospitals

CO has 108 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of 18.9% places it above the state median. Among 34 size-comparable peers (56-224 beds), the median margin is -1.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (56-224), prioritizing same-state peers. 34 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PEAK VIEW BEHAVIORAL HEALTH (Target)CO112$35.9M18.9%
POUDRE VALLEY HOSPITALCO218$722.4M10.8%
MEDICAL CENTER OF THE ROCKIESCO180$541.1M11.6%
CENTURA ST ANTHONY HOSPITALCO220$483.2M1.2%
BOULDER COMMUNITY HOSPITALCO139$418.3M-1.6%
CENTURA PARKER ADVENTIST HOSPICO162$351.5M12.9%
NORTH COLORADO MEDICAL CENTERCO202$321.9M-13.1%
CENTURA PORTER ADVENTIST HOSPICO180$319.8M-10.5%
GOOD SAMARITAN MEDICAL CTRCO183$314.3M-1.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$755K+210bp18mo
Cost to Collect4.5%2.5%$719K+200bp12mo
Denial Rate Reduction12.0%6.5%$712K+198bp12mo
A/R Days Reduction5200.0%3800.0%$437K+122bp9mo
Clean Claim Rate88.0%96.0%$23K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$755K
Cost to Collect
$719K
Denial Rate Reduction
$712K
A/R Days Reduction
$437K
Clean Claim Rate
$23K
Total EBITDA Uplift$2.6M
Current EBITDA$6.8M
+ RCM Uplift+$2.6M
Pro Forma EBITDA$9.4M
Current Margin18.9%
Pro Forma Margin26.3%
WC Released (1x)$1.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$10.5M$71.3M6.82x46.8%
Base (11x exit)10.0x11.0x$10.5M$81.9M7.82x50.9%
Bull Case9.0x11.0x$9.4M$94.0M9.98x58.4%
Bull (12x exit)9.0x12.0x$9.4M$105.3M11.18x62.1%
Bear Case11.0x10.0x$11.5M$54.7M4.75x36.6%
Bear (11x exit)11.0x11.0x$11.5M$63.9M5.55x40.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumElevated Medicaid exposure (33.9%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 34 hospitals with 56-224 beds
  • Same-state prioritization (n=35)
  • Comp margins: P25=-10.1% / P50=-1.7% / P75=4.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.